Zurueck zur Suche

Reporte zur Charge EN9263

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
1Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1 GA 1 WI 1 DE 1 AZ 1

VAERS 1154155

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9263

kritisch
Staat
-
Alter
67,0
Geschlecht
M
Eingang
01.04.2021
Impfdatum
09.02.2021
Beginn
16.02.2021
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Condition aggravated Death Dyspnoea Dyspnoea exertional Orthopnoea Renal impairment

Symptomtext

DEATH Narrative: 66 yo male with PMH of HTN, HFpEF, COPD, T2DM, CKD, tobacco use disorder and bipolar disorder was found dead in his home on 2/16/2021 after police did a wellness check per request of patient's sister. Patient received the covid19 vaccine (Pfizer) on 2/9/2021, vaccine was administered without complications. No prior positive for covid19. After patient received his covid19 vaccine, he was seen at same day access for increased SOB/DOE, worsened orthopnea. Per progress notes, at this last appt, patient had expressed a number of medications which he was not willing to take, attributing his worsened health to their effects. Pt has continued spironolactone despite being advised to stop it by his medical provider. At the time of visit, provider noted that this kidney function was declining (patient does have CKD). Provider discussed the importance of medication adherence and patient was started on torsemide. Hctz was discontinued, minoxidil was increased due to patient preference. Prior to this same day access/express care visit, patient was hospitalized from 1/26 through 1/28/2021 for hypertensive urgency (211/105) and that at that time, pt already had orthopnea, SOB, and dyspnea. Patient was also admitted from 1/7 to 1/8 and left AMA. While inpatient, his MRI revealed a pontine lacunar infarct that was found to be chronic. It was recommended that patient be treated with aspirin/plavix for 21 days then aspirin alone but patient declined.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1366981

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9263

moderat
Staat
CA
Alter
83,0
Geschlecht
F
Eingang
02.06.2021
Impfdatum
05.02.2021
Beginn
06.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anxiety Balance disorder Decreased appetite Dehydration Dizziness Flatulence Hyperacusis Insomnia Pollakiuria SARS-CoV-1 test Sensitivity to weather change Sitting disability

Symptomtext

gas; balance problems; dizziness; sensitivity to being enclosed inside warm rooms (above 66 degrees); sleeplessness; anxiety; inability to sit still; dehydration; loss of appetite; frequent urination; sensitivity to noise; This is a spontaneous report from a contactable consumer. A 83-years-old non pregnant female pa-tient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot Number: EN9263, Expiration date: Unknown), dose 1 via an unspecified route of administration, in right arm on 05Feb2021 at 14:30 (at the age of 83-years-old) as single dose for COVID-19 immun-isation and the patient received second dose of BNT162B2 (Solution for injection, Lot Number: EL6203, Expiration date: Unknown), via an unspecified route of administration, in right arm on 25Feb2021 at 11:15 AM (at the age of 83-years-old) as single dose for COVID-19 immunization. The patient medical history included arthritis and spinal stenosis. The Patient received concomitant medications in two weeks which included phytosterols nos and chondroitin sulfate sodium, glucosa-mine hydrochloride, multi-vitamins. Patient did not receive any other vaccine within four weeks. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. The patient had no known allergies. The patient had experienced gas, balance problems, dizziness, sensitivity to being enclosed inside warm rooms (above 66 degrees), sleeplessness, anxiety, inability to sit still, dehydration, loss of appetite, frequent urination and sensitivity to noise on 06Feb2021 at 19:00. There has not been any pain at the injection site or anywhere else on her body. No treatment received for events. The patient went to physician or other healthcare professional of-fice/clinic visit, Emergency room/department or urgent care due to events. The patient underwent lab tests and procedures which included nasal swab test on 05Feb2021 and 25Feb2021 result was nega-tive. The outcome of all events was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dehydration
Hospital-Tage
-
Labordaten
Test Date: 20210205; Test Name: COVID-19 TEST; Result Unstructured Data: Test Result:Negative; Test Date: 20210225; Test Name: COVID-19 TEST; Result Unstructured Data: Test Result:Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Arthritis; Spinal stenosis
Andere Medikamente
CHOLESTOFF ORIGINAL; GLUCOSAMINE/CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE HYDROCHLORIDE]
Allergien
-
Vorherige Impfungen
-

VAERS 1661573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9263

mild
Staat
GA
Alter
53,0
Geschlecht
F
Eingang
01.09.2021
Impfdatum
22.03.2021
Beginn
01.04.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymph node pain Lymphadenopathy

Symptomtext

Swollen lymph node on my left collar/ Others on left side around armpit and neck swollen.; Swollen lymph node on my left collar bone that was painful; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN9263) via an unspecified route of administration in the left arm on 22Mar2021 at 09:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included cholesterol high and seasonal allergy (going through allergy shots for seasonal allergies). Concomitant medications included allergy shots from unknown date. The patient previously took morphine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 01Apr2021, the patient experienced swollen lymph node on the left collar bone that was painful. Others on left side around armpit and neck swollen which was still swollen but no longer painful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful lymph nodes was resolved on an unknown date in Apr2021; while that of swollen lymph node on my left collar bone and others on left side around armpit was and neck swollen were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymph node pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Cholesterol high; Seasonal allergy (Going through allergy shots for seasonal allergies)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1659717

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9263

mild
Staat
WI
Alter
74,0
Geschlecht
F
Eingang
31.08.2021
Impfdatum
19.02.2021
Beginn
18.08.2021
Tage bis Beginn
180,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Groin pain Pollakiuria Urinary tract infection

Symptomtext

FREQUENT URINATION, GROIN PAIN - 2 WEEKS - UTI - PRESCRIBED ANTIBIOTICS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Groin pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NO
Vorgeschichte
SLEEP APNEA, FIBROMYALGIA, DIABETIC, HIATAL HERNIA, SJOGREN'S SYNDROME, DIVERTICULOSIS, COLON POLYPS, THORACIC ARTHRITIS OSTEOPENIA
Andere Medikamente
AVENOVA EYE WASY, CYCLOBENZAPRINE, DOXYCYCLINE, FISH OIL, FLOUCINONIDE, FLUTICASONEPROPIONATE CREAM, HYDROCORTISONE, LORATADINE, METRONIDAZOLE, NAPROXIN, RESTASIS, TETAINE MGD EYE DROPS, ZOLOFT, TRAZODONE, DIOVAN, METFORMIN, TRULICITY
Allergien
HYDROCHOLOROTHIIAZIDE, AMITRIPTYLINE, STATINS, WOOL
Vorherige Impfungen
-

VAERS 1652284

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9263

mild
Staat
DE
Alter
71,0
Geschlecht
M
Eingang
28.08.2021
Impfdatum
11.02.2021
Beginn
16.03.2021
Tage bis Beginn
33,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash macular Rash pruritic

Symptomtext

Red spots on front and back of my body and some on both legs; extreme itching, hundred of itchy spots; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9263) via an unspecified route of administration in the left arm on 11Feb2021 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, sarcoid and rheumatoid arthritis (RA). Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and tamsulosin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via an unspecified route of administration in the left arm on 21Jan2021 as a single dose for COVID-19 immunisation. The patient also previously received niacin (MANUFACTURER UNKNOWN), methotrexate (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN) and developed allergy to all the drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient experienced red spots on front and back of his body and some on both legs, extreme itching and hundreds of itchy spots. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with prednisolone and photo therapy. The clinical outcome for the events red spots on front and back of his body and some on both legs and extreme itching, hundreds of itchy spots were resolving. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash macular
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Diabetes; Rheumatoid arthritis (RA); Sarcoid
Andere Medikamente
OMEPRAZOLE; METFORMIN; LISINOPRIL; TAMSULOSIN
Allergien
-
Vorherige Impfungen
-

VAERS 2126118

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9263

gering
Staat
AZ
Alter
72,0
Geschlecht
F
Eingang
19.02.2022
Impfdatum
18.02.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Hair texture abnormal Trichorrhexis

Symptomtext

Hair changed dramatically after first vaccine, became very dry, brittle; became very dry, brittle; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Feb2021 09:00 (Lot number: EN9263) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hashimotos Disease" (unspecified if ongoing); "CVID (immune deficiency)" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; ESTRADIOL; THIOTHIXENE [TIOTIXENE] and Multivitamin. The following information was reported: HAIR DISORDER (non-serious), outcome "not recovered", described as "Hair changed dramatically after first vaccine"; HAIR TEXTURE ABNORMAL (non-serious), outcome "not recovered", described as "became very dry, brittle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hair disorder, hair texture abnormal was with weekly IV fluids for six months. Clinical course: If covid prior vaccination and if covid tested post vaccination were reported as no. No known allergies. If other vaccine in four weeks was no. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood test
Hospital-Tage
-
Labordaten
Test Date: 20210107; Test Name: blood test; Result Unstructured Data: Test Result:normal; Test Date: 20210404; Test Name: blood test; Result Unstructured Data: Test Result:plummeted; Comments: Bloodwork results showed kidney, liver, and vitamin D values plummeted
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Common variable immunodeficiency; Hashimoto's disease
Andere Medikamente
SYNTHROID; ESTRADIOL; THIOTHIXENE [TIOTIXENE]
Allergien
-
Vorherige Impfungen
-